BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3755651)

  • 1. Chemosensitization of lomustine by misonidazole, benznidazole, and RSU 1069.
    Workman P
    Cancer Treat Rep; 1986 Sep; 70(9):1139-40. PubMed ID: 3755651
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
    Lee FY; Workman P
    Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitization by lipophilic nitroimidazoles.
    Twentyman PR; Workman P
    Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of mouse lung tumors to combinations of CCNU and misonidazole.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):627-30. PubMed ID: 7107386
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
    Siemann DW; Alliet K; Maddison K; Wolf K
    Cancer Treat Rep; 1985 Dec; 69(12):1409-14. PubMed ID: 3841024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinations of cyclophosphamide and misonidazole in the KHT sarcoma.
    Siemann DW; Sutherland RM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):647-50. PubMed ID: 7107391
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
    Cole S; Stratford IJ; Fielden EM; Adams GE; Leopold W; Elliott W; Suto M; Sebolt-Leopold J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):545-8. PubMed ID: 1735694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
    Hill SA; Bauer KD; Keng PC; Siemann DW
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.
    Hill SA; Keng PC; Siemann DW
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1615-8. PubMed ID: 6480449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
    Binger M; Workman P
    Cancer Chemother Pharmacol; 1991; 29(1):37-47. PubMed ID: 1742848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
    Durand RE; Chaplin DJ
    Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
    Workman P; Twentyman PR
    Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.